BioNexus Gene Lab Corp. Public Float
BioNexus Gene Lab Corp. (BGLC) had Public Float of $4.81 million as of 2025-06-30, per its 10-K filed 2026-04-14.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-04-14
- 2025-06-30: Entity Public Float $4.81M.
- 2024-06-30: Entity Public Float $8.16M.
- 2023-06-30: Entity Public Float $66.50M.
- 2022-12-31: Entity Public Float $48.49M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $4.81M 10-K · filed 2026-04-14 |
| 2024-06-30 | $8.16M 10-K/A · filed 2025-04-29 |
| 2023-06-30 | $66.50M 10-K/A · filed 2024-05-31 |
| 2022-12-31 | $48.49M 10-K/A · filed 2024-05-31 |
| 2021-06-30 | $41.74M 10-K · filed 2022-04-06 |
| 2020-06-30 | $0.00 10-K · filed 2021-03-30 |
| 2019-06-30 | $0.00 10-K · filed 2020-03-31 |
| 2018-06-30 | $74.63M 10-Q · filed 2019-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |